Lupin

Lupin Official page of Lupin - A global pharmaceutical company with over 50 years of expertise in by prescriptions.
(265)

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products and APIs in over 100 markets in the U.S., India, South Africa and across Asia Pacific (APAC), Latin America (LATAM), Europe and Middle-East regions. The Company enjoys leadership position in

the cardiovascular, anti-diabetic, and respiratory segments and has significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS) and women’s health areas. Lupin is the third largest pharmaceutical company in the U.S. The company invested 9.6% of its revenue on research and development in FY21. Lupin has 15 manufacturing sites, 7 research centers, more than 20,000 professionals working globally, and has been consistently recognized as a 'Great Place to Work' in the Biotechnology & Pharmaceuticals sector. Please visit www.lupin.com for more information.

Lupin announced the launch of Dapagliflozin Tablets, 5 mg and 10 mg, in the United States. Read More: https://bit.ly/3PX...
13/04/2026

Lupin announced the launch of Dapagliflozin Tablets, 5 mg and 10 mg, in the United States. Read More: https://bit.ly/3PXD1sh

In a discussion with ET Digital, Ramesh Swaminathan, Executive Director, Global CFO, and Head of API Plus, Sustainabilit...
13/04/2026

In a discussion with ET Digital, Ramesh Swaminathan, Executive Director, Global CFO, and Head of API Plus, Sustainability, and IT at Lupin, shares insights on how artificial intelligence is transforming the pharmaceutical value chain — from drug discovery and clinical trials to manufacturing. He also shares how Lupin is deploying Generative AI across the organization to drive efficiency, accelerate innovation, and enable enterprise‑wide transformation.

Watch the full conversation to learn how AI is reshaping the future of pharma. Visit: https://www.youtube.com/watch?v=TQ-Lri-l4yQ&t=57s

Enjoy the videos and music that you love, upload original content and share it all with friends, family and the world on YouTube.

Read an article by Dr. Gaurish Kenkre, Senior General Manager and Centre Head, Atharv Ability, in which he emphasizes th...
13/04/2026

Read an article by Dr. Gaurish Kenkre, Senior General Manager and Centre Head, Atharv Ability, in which he emphasizes that through early intervention, structured care, and sustained support, individuals can successfully rebuild independence, confidence, and a meaningful quality of life. Visit: https://bit.ly/4ef2RBR

Strong bones = strong you. Decode the riddle!
11/04/2026

Strong bones = strong you. Decode the riddle!

Lupin Human Welfare & Research Foundation, the CSR arm of global pharma major Lupin Ltd., inaugurated two Non‑Communicab...
10/04/2026

Lupin Human Welfare & Research Foundation, the CSR arm of global pharma major Lupin Ltd., inaugurated two Non‑Communicable Disease (NCD) Corners in Karauli and Hindaun, Rajasthan. Read More: https://bit.ly/4edUwOT

Lupin received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Appl...
10/04/2026

Lupin received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets. Read More: https://bit.ly/4t2NLnP

Real change doesn’t happen overnight. It begins when someone is given the right support, the right skills, and a chance ...
09/04/2026

Real change doesn’t happen overnight. It begins when someone is given the right support, the right skills, and a chance to build something of their own.

Dashrath, a farmer from Bharatpur’s journey, reflects on how consistent guidance and access to resources can help families move away from uncertainty and towards stability. It’s about staying rooted, creating dignity in everyday work, and building a future that feels secure.

When one life becomes stronger, the impact is felt across the whole family.

Lupin received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Appl...
09/04/2026

Lupin received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Dapagliflozin Tablets, 5 mg and 10 mg. Read More: https://bit.ly/3PQ8mwX

In an article published by Business Standard, Lupin’s CEO, Vinita Gupta, and Managing Director, Nilesh Gupta, share insi...
08/04/2026

In an article published by Business Standard, Lupin’s CEO, Vinita Gupta, and Managing Director, Nilesh Gupta, share insights into the company’s biosimilars strategy, outlining plans to launch biosimilars across multiple global markets in the coming years. Anchored by our strong presence in India, Lupin is well-positioned to play a meaningful role in emerging therapy segments as new treatments continue to evolve. To know more, visit: https://bit.ly/4dBdhLV

Address

Mumbai

Opening Hours

Monday 9:30am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+912266402323

Website

Alerts

Be the first to know and let us send you an email when Lupin posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Lupin:

Shortcuts

Share

Category

A global pharmaceutical company with 50 years of expertise in bringing you better health with care.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products and APIs in over 100 markets in the U.S., India, South Africa and across Asia Pacific (APAC), Latin America (LATAM), Europe and Middle-East regions.

The Company enjoys leadership position in the cardiovascular, anti-diabetic, and respiratory segments and has significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS) and women’s health areas. Lupin is the third largest pharmaceutical company in the U.S. by prescriptions and in India by global revenues. The Company invests 9.6 % of its revenues on research and development.

Lupin has fifteen manufacturing sites, seven research centers, more than 20,000 professionals working globally, and has been consistently recognized as a 'Great Place to Work' in the Biotechnology & Pharmaceuticals sector.